投稿咨詢
Epigenomics provides the forum to address the rapidly progressing research developments in this ever-expanding field; to report on the major challenges ahead and critical advances that are propelling the science forward. The journal delivers this information in concise, at-a-glance article formats – invaluable to a time constrained community.
Substantial developments in our current knowledge and understanding of genomics and epigenetics are constantly being made, yet this field is still in its infancy. Epigenomics provides a critical overview of the latest and most significant advances as they unfold and explores their potential application in the clinical setting.
《Epigenomics》是一本由Future Medicine Ltd.出版商出版的專業醫學期刊，該刊創刊于2009年，刊期16 issues/year，該刊已被國際權威數據庫SCIE收錄。在中科院最新升級版分區表中，該刊分區信息為大類學科：醫學 2區，小類學科：遺傳學 2區；在JCR（Journal Citation Reports）分區等級為Q2。該刊發文范圍涵蓋遺傳學等領域，旨在及時、準確、全面地報道國內外遺傳學工作者在該領域取得的最新研究成果、工作進展及學術動態、技術革新等，促進學術交流，鼓勵學術創新。2021年影響因子為4.357，平均審稿速度>12周，或約稿。
| 大類學科 | 分區 | 小類學科 | 分區 | Top期刊 | 綜述期刊 |
| 醫學 | 3區 | GENETICS & HEREDITY 遺傳學 | 4區 | 否 | 否 |
| JCR分區等級 | JCR所屬學科 | 分區 | 影響因子 |
| Q2 | GENETICS & HEREDITY | Q2 | 4.357 |
| 影響因子 | h-index | Gold OA文章占比 | 研究類文章占比 | OA開放訪問 | 平均審稿速度 |
| 4.357 | 44 | 17.29% | 82.73% | 未開放 | >12周，或約稿 |
課題、SCI/EI/SSCI怎么寫？